أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - capsules gastro-resistant - 150 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - pancreatic exocrine deficiency

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - capsules gastro-resistant - 300 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine deficiency.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - capsules gastro-resistant - 400 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine insufficiency

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

bgp products ltd - pancreas powder - granules gastro-resistant - 60.12 milligram - enzyme preparations - multienzymes (amylase, lipase, protease) - for the treatment of pancreatic exocrine insufficiency

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

bgp products ltd - lactulose - oral solution - 3.335 g/5ml - osmotically acting laxatives - osmotically acting laxatives - constipation hepatic encephalopathy (he): treatment and prevention of hepatic coma or precoma

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

bgp products ltd - dydrogesterone - film coated tablet - 10 milligram - pregnadien derivatives - urinary system and sex hormones - in the management of conditions associated with progesterone insufficiency: dysmenorrhoea, endometriosis, infertility, irregular menstrual cycles and pre-menstrual syndrome. the drug may be used with an estrogen in the management of dysfunctional bleeding or secondary amenorrhoea, or in association with estrogen in hormone replacement therapy.

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - abbott hbv sequencing is an in vitro assay for determining the dna sequence of the reverse transcriptase (rt) region of the polymerase (pol) gene of hepatitis b virus (hbv). the test is intended for use as an aid in the management of patients with chronic hbv. the abbott hbv sequencing assay is not intended for use in the screening of blood, plasma, or tissue donors for hbv, or to be used as a diagnostic test to confirm the presence of hbv infection.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - mebeverine hydrochloride - coated tablets - 135 milligram

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol, dydrogesterone - film coated tablet - 1mg/5mg milligram - progestogens and estrogens, fixed combinations - : genito urinary system and sex hormones, progestogens and oestrogens, fixed combinations - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 12 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the abbott prismr hbcore assay is an in vitro chemiluminescent immunoassay (chlia) for the qualitative detection of total antibody to hepatitis b core antigen (anti-hbc) in human serum and plasma. it is intended to be used as a screen for blood and plasma to prevent transmission of hepatitis b virus (hbv) to recipients of blood and blood components and as an aid in the diagnosis of hbv infection. it is also intended for use in testing serum and plasma specimens to screen cell, tissue and organ donors when specimens are obtained while the donor’s heart is still beating. use with abbott prism system.